BDBM303128 5-[6-methyl-1-(3,3,5,5-tetramethylcyclohexyl)-2-{[4-(trifluoromethoxy)phenyl]amino}-1H-benzimidazol-5-yl]-1,2-oxazol-3-ol::US10137110, Example 2-37

SMILES: Cc1cc2n(C3CC(C)(C)CC(C)(C)C3)c(Nc3ccc(OC(F)(F)F)cc3)nc2cc1-c1cc(O)no1

InChI Key: InChIKey=QRNMTNCXNVMNDI-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 303128   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
IDH1 R132H (Homo sapiens (Human))	BDBM303128 (5-[6-methyl-1-(3,3,5,5-tetramethylcyclohexyl)-2-{[...) Show SMILES Cc1cc2n(C3CC(C)(C)CC(C)(C)C3)c(Nc3ccc(OC(F)(F)F)cc3)nc2cc1-c1cc(O)no1 Show InChI InChI=1S/C28H31F3N4O3/c1-16-10-22-21(11-20(16)23-12-24(36)34-38-23)33-25(32-17-6-8-19(9-7-17)37-28(29,30)31)35(22)18-13-26(2,3)15-27(4,5)14-18/h6-12,18H,13-15H2,1-5H3,(H,32,33)(H,34,36)	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a	n/a
Bayer Pharma Aktiengesellschaft US Patent					Assay Description Levels of (2R)-2-hydroxyglutarate (2HG) were measured in medium of a cell line with overexpression of mutated isocitrate dehydrogenase (mIDH) protein...				US Patent US10137110 (2018) BindingDB Entry DOI: 10.7270/Q2J968F3
					More data for this Ligand-Target Pair
IDH1 R132H (Homo sapiens (Human))	BDBM303128 (5-[6-methyl-1-(3,3,5,5-tetramethylcyclohexyl)-2-{[...) Show SMILES Cc1cc2n(C3CC(C)(C)CC(C)(C)C3)c(Nc3ccc(OC(F)(F)F)cc3)nc2cc1-c1cc(O)no1 Show InChI InChI=1S/C28H31F3N4O3/c1-16-10-22-21(11-20(16)23-12-24(36)34-38-23)33-25(32-17-6-8-19(9-7-17)37-28(29,30)31)35(22)18-13-26(2,3)15-27(4,5)14-18/h6-12,18H,13-15H2,1-5H3,(H,32,33)(H,34,36)	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Bayer Pharma Aktiengesellschaft US Patent					Assay Description mIDH1 catalyzes the NADPH-dependent reduction of alpha-ketoglutarate (α-KG) to (2R)-2-hydroxyglutarate (2-HG). NADPH consumption was measured by...				US Patent US10137110 (2018) BindingDB Entry DOI: 10.7270/Q2J968F3
					More data for this Ligand-Target Pair